Suttorp, M., & Kulozik, A. (2018). Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: Results from a phase III trial. Leukemia, 32(7), . https://doi.org/10.1038/s41375-018-0179-9
Chicago Style (17th ed.) CitationSuttorp, Meinolf, and Andreas Kulozik. "Front-line Imatinib Treatment in Children and Adolescents with Chronic Myeloid Leukemia: Results from a Phase III Trial." Leukemia 32, no. 7 (2018). https://doi.org/10.1038/s41375-018-0179-9.
MLA (9th ed.) CitationSuttorp, Meinolf, and Andreas Kulozik. "Front-line Imatinib Treatment in Children and Adolescents with Chronic Myeloid Leukemia: Results from a Phase III Trial." Leukemia, vol. 32, no. 7, 2018, https://doi.org/10.1038/s41375-018-0179-9.
Warning: These citations may not always be 100% accurate.